ASQ is a global community of people passionate about quality, who use the tools, their ideas and expertise to make our world work better. ASQ: The Global Voice of Quality.

References - Pharmaceutical GMP Professional Certification - CPGP


Code of Federal Regulations 21CFR (including FDA Preamble [Fed Register Vol. 43 No. 190] ) documents

  • 210-211 Current Good Manufacturing Practice in Manufacture, Processing, Packing, or Holding Finished Pharmaceuticals
  • Section 7 Recalls (Including Product Corrections)
  • Part 11 Electronic Records ; electronic signatures
  • Part 58 Good Laboratory Practices for Non-clinical Laboratory Studies
  • 1308.11-1308.15 requirement for storage of controlled substances
  • 205 Guidelines for State Licensing of Wholesale Prescription Drug Distributors
  • 21 CFR 314.81: Applications for FDA Approval to Market a New Drug

Food and Drug Administration (FDA) Guidances

  • Changes to an Approved NDA or ANDA
  • Container and Closure Integrity Testing in Lieu of Sterility Testing as a Component of the Stability Protocol for Sterile Products
  • Container Closure Systems for Packaging Human Drugs and Biologics
  • Current Good Manufacturing Practice for Combination Products
  • for the Submission Documentation for Sterilization Process Validation in Applications for Human and Veterinary Drug Products
  • General Principles of Software Validation
  • Powder Blends and Finished Dosage Units--Stratified In-Process Dosage Unit Sampling and Assessment
  • Product Recalls, Including Removals and Corrections
  • Q1A (R2) Stability Testing of New Drug Substances and Products
  • Q1E Evaluation of Stability Data
  • Q3B( R) Impurities in New Drug Products
  • Quality Systems Approach to Pharmaceutical CGMP Regulations
  • Sterile Drug Products Produced by Aseptic Processing

FDA Guide to Inspections

  • Investigations Operations Manual (IOM) 2008
  • Microbiological Pharmaceutical Quality Control Laboratories
  • Pharmaceutical Quality Control Laboratories
  • Topical Drug Products
  • Validation of Cleaning Processes
  • High Purity Water Systems
  • Biotechnology inspection guide reference materials and training aids

FDA Guidelines

  • Investigational New Drug Applications (INDs) for Phase 1 Studies of Drugs 
  • Validation of the Limulus Amebocyte Lysate Test
  • Inspections of Sterile Drug Substance Manufacturers
  • Inspections of Oral Solid Dosage Forms Pre/Post Approval Issues for Development and Validation
  • Investigating Out of Specification Test Results
  • General Principles of Process Validation

FDA Policy Guides (Compliance Policy Guides (CPG))

  • Preapproval Inspections 7346.832
  • Sterile Drug Process Inspections Program 7356.002A
  • Compliance Program Guidance Manual for FDA Staff: Drug Manufacturing Inspections Program 7356.002
  • Compliance Program Guidance Manual 7356.002F Active Pharmaceutical Ingredient (API) Process Inspection

Pharmaceutical Inspection Convention/Co-operation Scheme (PIC/S)

  • PE 008-2 Explanatory Notes for Industry on the Preparation of a Site Master File
  • PE 009-10 PIC/S GMP guide Part 1, Part 2 and Annexes
  • PE 010-3 PIC/S Guide to Good Practices for the Preparation of Medicinal Products in Healthcare Establishments ?
  • Pl 006-3 Recommendations on Validation Master Plan Installation and Operational Qualification Non-Sterile Process Validation Cleaning Validation
  • Pl 007-4 Recommendation on the Validation of Aseptic Processes
  • Pl 009-3 Aide-Memoire on Inspection of Utilities
  • Pl 010-4 Procedure for Handling Rapid Alerts and Recalls Arising from Quality Defects
  • Pl 011-3 ?Good Practices for computerized systems in regulated "GXP" environments
  • Pl 012-3 ?Recommendation on Sterility Testing
  • Pl 014-3 Recommendation on Isolators Used for Aseptic Processing and Sterility Testing

American National Standards Institute (ANSI)/International Organization for Standards (ISO)

  • ANSI/ISO/IEC 17025 General Requirements for the Competence of Testing and Calibration Laboratories
  • ISO 19011:2002 Guidelines for Quality and Environmental Management Systems Auditing
  • ISO 9001-2000 Quality Management Systems Requirements
  • ISO 14644 Cleanrooms


  • Directive 2001/82/EC on the Community Code Relating to Veterinary Medicinal Products
  • Directive 2003/94/EC Laying Down the Principles and Guidelines of Good Manufacturing Practice in Respect of Medicinal Products for Human and Investigational Medicinal Products for Human Use as amended
  • Directive 2001/83/EC on the Community Code Relating to human medicinal products

European Good Manufacturing Practice

  • Eudralex Volume 4, Parts I and II and Annexes

Health Canada Guidelines

  • 0069 Guidelines for Temperature Control of Drug Products During Storage and Transportation
  • Good Manufacturing Practices Guidelines

International Conference on Harmonization (ICH) Documents

  • ICH Q1A Stability testing of new drug substances and products
  • ICH Q7 Good Manufacturing Guide for Active Pharmaceutical Ingredients
  • ICH Q9 Quality Risk Management
  • ICH Q10 Pharmaceutical Quality System
  • ICH Q11 Development and manufacture of drug substances
  • ICH Q2A Text on Validation of Analytical Procedures
  • ICH Q2B Validation of Analytical Procedures: Methodology
  • ICH Q3A Impurities in New Drug Substances
  • ICH Q3C Impurities: Guideline for Residual Solvents
  • ICH Q6A Specifications: Test procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances
  • ICH Q8 Pharmaceutical Development

International Society for Pharmaceutical Engineering (ISPE) Guidelines

  • ISPE GAMP V (Good Automated Manufacturing Practice) Guide for Validation of Automated Systems

U.S. Drug Enforcement Agency (DEA)

  • 21 USC Sec. 812: L.91-513 Controlled substances act

Parenteral Drug Association (PDA) Technical Reports

  • Report No. 1 Validation of Steam Sterilization Cycles
  • Report No. 39 Cold Chain Guidance for Medicinal Products
  • Report No. 60 Process validation: a lifecycle approach
  • Report No. 30 Parametric release of Pharmaceutical and Medical device products terminally sterilized by moist heat
  • Report No. 58
  • Report No. 43
  • 54
  • 61
  • 62
  • 59
  • 29


  • Pharmaceutical Administration, Regulation and Drug Development in Japan

European Pharmacopeia

  • 2.2.44 Total Organic Carbon in Water for Pharmaceutical Use
  • 2.2.46 Chromatographic Separation Techniques
  • 2.6.7 Mycoplasmas

Australian Guidelines

  • TGA Guidelines for Sterility Testing of Therapeutic Goods
  • TGA Amended EU (EMEA/410/01) Guideline Note for Guidance on Minimizing the Risk of Transmitting Animal Spongiform Encephalopathy Agents via Human and Veterinary Medicinal Products

United States Pharmacopeia (USP)

  • General chapters related to pharmaceutical analytical methods and practices

World Health Organization (WHO) documents

  • Good Manufacturing Practices (A Compendium of Guidelines and Related Materials Volume 2: Good Manufacturing Practices and Inspection)
  • QAS/04.068/Rev. 2 Good Distribution Practices for Pharmaceutical Products
  • Quality Assurance of Pharmaceuticals: A Compendium of Guidelines and Related Materials, 2004 WHO

FDA Center for Biologics Evaluation & Research (CBER) Guidances

  • Bioanalytical Method Validation
  • Biological Indicator (BI) Premarket Notification [510(k)] Submissions
  • Biological Product Deviation Reporting for Licensed Manufacturers of Biological Products Other than Blood and Blood Components
  • Characterization and Qualification of Cell Substrates and Other Biological Starting Mat'ls Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases
  • Points to Consider (PTC) in the Characterization of Cell Lines Used to Produce Biologicals
  • Q5A Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin
  • Q5E Comparability of Biotechnological/Biological Product Subject to Changes in their Manufacturing Process

9CFR and 21CFR documents (related to biologics)

  • 9 CFR Parts related to Animal Biologics Quality Requirements in Manufacturing
  • 21 CFR 601 Licensing
  • 21 CFR 600 Biological Products: General
  • 21 CFR 610 selected sections critical to biologic drugs

Compliance Policy Guides (CPGs)

  • CPG 7345.848 Inspection of Biological Drug Products
  • Guide to Inspections of Lyophilization of Parenterals

IPEC Significant Change Guide

IPEC GMP Guide for Pharmaceutical Excipients

Return to "Prepare for the exam."

Sign In

Forgot User Name?
Forgot Password?

Join ASQ Now!

Featured advertisers